Use of Artificial Intelligence with Epigenetic Biomarkers

Use of Artificial Intelligence with Epigenetic Biomarkers

Aging is the principal risk factor in many chronic diseases such as cancer, cardiovascular, and metabolic & neurological diseases. There is therefore great interest in the dev...

Read More

Despite US Law, Fewer Than Half of US Clinical Trials Report Results by the Required Deadline

Despite US Law, Fewer Than Half of US Clinical Trials Report Results by the Required Deadline

Patients, researchers, pharmaceutical companies, clinicians, amongst others, all rely on the release of clinical trial results. Despite this, a report published by The Lancet ...

Read More